1,602 hedge funds and large institutions have $108B invested in Amgen in 2017 Q3 according to their latest regulatory filings, with 93 funds opening new positions, 611 increasing their positions, 643 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

0.54% more ownership

Funds ownership: 78.5%79.03% (+0.54%)

5% less call options, than puts

Call options by funds: $1.3B | Put options by funds: $1.36B

5% less repeat investments, than reductions

Existing positions increased: 611 | Existing positions reduced: 643

Holders
1,602
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
88
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.3B
Puts
$1.36B
Net Calls
Net Calls Change

Top Buyers

1 +$380M
2 +$260M
3 +$259M
4
Goldman Sachs
Goldman Sachs
New York
+$185M
5
PI
Putnam Investments
Massachusetts
+$158M

Top Sellers

1 -$394M
2 -$236M
3 -$206M
4
Flossbach Von Storch
Flossbach Von Storch
Germany
-$181M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$162M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$622M
27
$609M
28
$608M
29
$595M
30
$593M
31
$546M
32
$535M
33
$525M
34
$521M
35
$506M
36
$500M
37
$499M
38
$479M
39
$456M
40
$435M
41
$419M
42
$404M
43
$402M
44
$396M
45
$387M
46
$367M
47
$354M
48
$336M
49
$329M
50
$316M